Bloomberg News

J&J’s Scios Unit Charged in Misbranding of Heart Drug Natrecor

July 08, 2011

July 8 (Bloomberg) -- Johnson & Johnson’s Scios unit was charged with misbranding the heart drug Natrecor, federal prosecutors in San Francisco said in a court filing alleging the medicine’s labeling lacked adequate directions for use.

To contact the reporter on this story: Karen Gullo in San Francisco at

To contact the editor responsible for this story: Michael Hytha at

The Good Business Issue
blog comments powered by Disqus